期刊文献+

维持性肾替代治疗患者腹膜透析转血液透析的因素探讨 被引量:3

Causes of end stage renal disease patients transfering from peritonealdialysis to hemodialysis
原文传递
导出
摘要 目的:分析终末期肾病患者腹膜透析转血液透析的原因,并探讨其相关因素。方法:回顾分析176例行腹膜透析治疗的终末期肾病患者的临床资料,将退出腹膜透析转向血液透析的患者设为转换组,继续行维持性非卧床腹膜透析的患者作为对照组,并行对比分析。结果:176例腹膜透析患者中有23例(13.1%)改为血液透析治疗,其中7例为腹膜透析相关性腹膜炎,6例为透析不充分,5例为腹透管功能障碍,3例为超滤衰竭(ultrafiltration failure,UFF),其他2例。与对照组相比,转换组患者年龄较大,文化程度低,原发病为糖尿病肾病较多,开始透析时肌酐清除率(creatinine clearance rate,CCr)更低,营养不良及贫血程度较严重(P<0.05)。结论:腹膜透析相关性腹膜炎仍然是腹膜透析技术失败的主要原因,早期肾脏替代治疗,规范患者操作程序,改善患者贫血及营养状况有助于提高腹膜透析患者的技术存活率。 Objective: To analyze the reasons of patients transferring from peritoneal dialysis (PD) to hemodialysis and explore the risk factors. Methods: The clinic data of 176 patients who received peritoneal dialysis were analyzed retrospectively. The patients were divided into two groups and analyzed comparatively. Results: Among the 176 patients, 23 cases (13.1% ) transferred from PD to hemodialysis. The reasons for the transfer were PD associated peritonitis ( 7 cases, 30.4% ), insufficient dialysis ( 6 cases, 26.1% ), mechanical complications ( 5 cases, 21.7% ) , ultrafihration failure (3 cases, 13.0% ) and some other reasons (2 cases, 8.7% ). The switched cases had older age, lower culture, more diabetie patients, lower ereatinine clearance rate , more serious malnutrition and anemia. Conclusion: The PD associated peritonitis is the top reason for patients to transfer from PD to hemodialysis. Earlier stage renal replacement therapy, more standardized operational process and better nutrional state can improve the PD technical survival rate.
出处 《现代医学》 2011年第4期419-423,共5页 Modern Medical Journal
关键词 终末期肾病 腹膜透析 血液透析 end stage renal disease peritoneal dialysis hemodialysis
  • 相关文献

参考文献9

  • 1XUE J L, MA J Z, LOUIS T A, et al. Forecast of the number of patients with endstage renal disease in the United States to the year 2010[J]. J Am Soc Nephrol, 2001, 12(12): 2753-2758.
  • 2YANEZ-MO M, LARA-PEZZI E, SELGAS R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial ceils [ J ]. N Eagl J Med, 2003,348 ( 5 ) : 403- 413.
  • 3LOW K. Peritoneal dialysis utilization and outcome:what are we facing? [J]. Perit Dial Int, 2007,27 Suppl 2:S42-47.
  • 4CUETO-MANZANO A M, QUINTANA-PINA E, CORREAROTTER R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center[ J ]. Petit Dial Int,2001,21 (2) : 148-153.
  • 5STENVINKEL P, CHUNG S H, HEIMBURGER O, et al. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients[ J ]. Petit Dial Int, 2001, 21 ( Suppl 3 ) :S157-162.
  • 6FUNG F, SHERRARD D J, GILLEN D L, et al. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients [ J ]. Am J Kidney Dis, 2002,40 (2) : 307-314.
  • 7van BIESEN W, VANHOLDER R, LAMEIRE N. The role of peritoneal dialysis as the first-line renal replacement modality [J]. Petit Dial Int, 2000,20(4) :375-383.
  • 8SCHAUBEL D E, BLACK P G, FENTON S S. Trends in CAPD technique failure: Canada, 1981- 1997 [ J]. Perit Dial Int,2001,21 (4) :365-371.
  • 9DAVIES S J, PHILIPS L, GRIFFITHS A M, et al. What really happens to people on long-term peritoneal dialysis? [J]. Kidney Int,1998,54(4) :2207-2217.

同被引文献21

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部